Effectiveness And Impact Of Nirsevimab In Chile (NIRSE-CL)
Clinical trial NCT06511687 · UNKNOWN
Trial details
- NCT number
- NCT06511687
- Sponsor
- Instituto Sistemas Complejos de Ingeniería
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-01
- Primary completion
- 2024-10-01
- Enrollment
- 160000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.